Ep149: Nancy Stagliano on Precision Neuroscience
The Long Run with Luke Timmerman
Strategic Shift Towards Alzheimer's Lead Program
Exploring the pivotal decision to focus on Alzheimer's as a lead program due to financial constraints and the successful transaction with BMS. The chapter illustrates the CEO's validation, venture capitalists' support, and the unique challenges of drug development for rare diseases.
00:00
Transcript
Play full episode
Remember Everything You Learn from Podcasts
Save insights instantly, chat with episodes, and build lasting knowledge - all powered by AI.
